Clinical pharmacists can aid patients with uncontrolled T2DM

Clinical pharmacists can aid patients with uncontrolled T2DM
Clinical pharmacists can play a role in helping patients with poorly controlled type 2 diabetes, according to a case study published in the October issue of Clinical Diabetes.

(HealthDay)—Clinical pharmacists can play a role in helping patients with poorly controlled type 2 diabetes, according to a case study published in the October issue of Clinical Diabetes.

Travis E. Sonnett, Pharm.D., from Washington State University, and Tyler Galloway, Pharm.D., from the Mann-Grandstaff Veteran Affairs Medical Center—both in Spokane, examined the impact of a clinical pharmacy specialist on management of a wheelchair-bound, 64-year-old man with a history of uncontrolled (hemoglobin A1c [A1c], 10.0 percent). The patient reported poor adherence to his insulin regimen, but close adherence to his oral medication regimen. He experienced progression of peripheral neuropathy and retinopathy.

The authors reported that the clinical pharmacist used a motivational interview technique to discuss the patient's failure to follow the current insulin regimen and poor eating. They developed a plan to monitor progress and agreed on an initial goal of A1c <9 percent and a long-term goal of <8.0 percent, in accordance with the Veterans Affairs/Department of Defense (VA/DoD) guidelines. Follow-up was via phone contact and the pharmacist adjusted the insulin regimen in accordance with changes in blood glucose. At the end of 12 weeks, the patient's A1c was 7.1 percent, and he reported noticeable improvement in peripheral neuropathy and improvement in visual impairment.

"The case described here is considered a success within the VA/DoD setting by virtue of the patient's goal achievement," the authors write.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

T1DM insulin intensification patterns, outcomes studied

Jan 30, 2013

(HealthDay)—About half of youths with type 1 diabetes shift to a more intensive insulin regimen over time, which is associated with better glycemic control, according to research published in the January ...

FDA approves A1c test for diabetes diagnosis

May 29, 2013

(HealthDay)—The U.S. Food and Drug Administration has just cleared a hemoglobin A1c assay to be marketed for the diagnosis of diabetes, according to a May 24 press release issued by the agency.

Meds adherence self-report valid in type 2 diabetes

Dec 20, 2012

(HealthDay)—Self-reported measures of medication adherence in adults with type 2 diabetes are valid, although some self-reports are moderated by depression, according to a study published online Nov. 30 ...

Recommended for you

Pre-diabetes label 'unhelpful and unnecessary'

Jul 14, 2014

Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota.

User comments